Search results for: 'learning and developement'

This Frost & Sullivan analysis examines the global laboratory information management system (LIMS) market. The market is currently experiencing disruption due to a shift towards digitalization driven by automation, the industrial internet of things (IIoT), and smart technologies. This trend is transforming laboratory operations as it employs real-t...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

Blockchain is finally overcoming early confusion and hype. It is a spectrum technology that can be applied to achieve many possible outcomes. Its best uses are in the creation of trusted digital connective tissue in open, complex ecosystems and in the programmatic creation of digital value where it cannot be easily be replaced by centralized system...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

The Mobility Technology Opportunity Engine (TOE) covers innovations pertaining to EV Charging, V2X Platforms, LiDAR, and Autonomous Vehicle Development among others.The purpose of the Mobility Technology TOE is to raise awareness of global technology innovations in self-propelled ground-based mobile platforms that are not only technically significa...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

The development of augmented reality (AR), virtual reality (VR), and extended reality (XR) technologies expect to accelerate in upcoming years. Technology developers and adopters across various industries experiment with these innovations for mass deployment, driving the shift from product testing for specific application requirements to scaling th...